To identify tumor metastasis-related 5hmC modifications, we performed pairwise comparison between PT1 and MT1 (Group 1), and PT2 and MT2 (Group 2) based on their clinical characteristics (tumor size, Ki-67 index, and age). The gene discussed is MKI67; the disease is neoplasm.